Days with severe symptoms: An additional efficacy endpoint in immunotherapy trials

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 66, Issue 1, 2011, Pages 120-123

  Durham, S R ^a   Birk, A O ^b   Andersen, J S ^b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ALK ABELLÓ   (Denmark)

Author keywords

efficacy; endpoint; immunotherapy; severe; symptoms

Indexed keywords

BUDESONIDE; GRASS POLLEN VACCINE; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHLEUM PRATENSE; POLLEN ALLERGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOCONJUNCTIVITIS; SYMPTOM;

ADULT; CONJUNCTIVITIS, ALLERGIC; DOUBLE-BLIND METHOD; ENDPOINT DETERMINATION; FEMALE; HUMANS; IMMUNOTHERAPY; MALE; PHLEUM; PLANT EXTRACTS; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 78649981810     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2010.02434.x     Document Type: Article

References (6)

1. Emberlin JC,. Grass, tree and weed pollens. In:, Kay AB, editor. Allergy and allergic diseases. Vol 2 edn. Oxford, United Kingdom: Blackwell Science, 1997: 835-857.
2. Juniper EF, Guyatt GH,. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991; 21: 77-83.
3. Valovirta E, Myrseth SE, Palkonen S,. The voice of the patients: allergic rhinitis is not a trivial disease. Curr Opin Allergy Clin Immunol 2008; 8: 1-9.
4. Dahl R, Kapp A, Colombo G, De Monchy J, Rak S, Emminger W, et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablet for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 118: 434-440.
5. Scadding GK, Frølund L, Tholstrup B, Durham S,. Compliance during a long-term Phase III trial with the SQ-standardised grass allergy immunotherapy tablet. Allergy 2010; 65 (suppl. 92): 580.
6. Durham SR,. Sublingual immunotherapy: what have we learnt from the 'big trials'? Curr Opin Allergy Clin Immunol 2008; 8: 577-584.